1 – 16 of 16
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.
(
- Contribution to journal › Article
-
Mark
Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
(
- Contribution to journal › Article
- 2002
-
Mark
Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age.
(
- Contribution to journal › Article
-
Mark
A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
(
- Contribution to journal › Article
-
Mark
Progression of retinopathy in insulin-treated type 2 diabetic patients.
(
- Contribution to journal › Article
- 2001
-
Mark
Islet autoantibodies in the prediction of diabetes in school children
(
- Contribution to journal › Article
-
Mark
High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age
(
- Contribution to journal › Article
- 1999
-
Mark
Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables
(
- Contribution to journal › Article
-
Mark
Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia
(
- Contribution to journal › Article
- 1998
-
Mark
Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years
(
- Contribution to journal › Article
-
Mark
The frequency and severity of retinopathy are related to HbA(1c) values after, but not at, the diagnosis of NIDDM
(
- Contribution to journal › Article
- 1996
-
Mark
Islet cell antibodies at diagnosis, but not leanness, relate to a better cardiovascular risk factor profile 5 years after diagnosis of NIDDM
(
- Contribution to journal › Article
- 1995
-
Mark
Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetes
(
- Contribution to journal › Article
- 1994
-
Mark
Islet cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients
(
- Contribution to journal › Article
- 1993
-
Mark
β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients
(
- Contribution to journal › Article
- 1992
-
Mark
Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and c-peptide to measure insulin secretion
(
- Contribution to journal › Article